ADx NeuroSciences logo — company profile

ADx NeuroSciences

Founded 2011 Belgium Belgium 23 employees Biotechnology

General Information

Company Name ADx NeuroSciences
Founded Year 2011
Location Belgium Belgium +1
Founders / Decision Makers
Team member
Employees 23
Industries Biotechnology
Social

Get notified when ADx NeuroSciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ADx NeuroSciences

ADx NeuroSciences is a biotechnology startup that specializes in developing advanced biomarker-assays for diagnosing various neurodegenerative diseases. Founded in 2011 by four experts in biomarker development and Alzheimer’s disease research, the company boasts more than 45 years of combined knowledge and experience in the field. ADx’s proprietary tests enable early detection of conditions such as Alzheimer's disease, Parkinson's disease, and traumatic brain injury, providing valuable patient information before symptoms appear. The company's technology benefits in vitro diagnostic companies by offering access to biomarkers and antibodies for use in automated platforms and test kits. Additionally, pharmaceutical companies utilize ADx assays and services to drive the design of large clinical trials for novel therapies. For potential collaborators or interested parties, more information can be found on their website at http://adxneurosciences.com/en/.

No funding data available for ADx NeuroSciences yet.

Get notified when ADx NeuroSciences raises funding

ADx NeuroSciences Alternatives & Competitors

ADx NeuroSciences vs

Pioneering faster diagnosis of your patients through advancements in biochemical, biomarker, and gen...

25 employees
Health Care
ADx NeuroSciences vs

Your Provider for Metabolite Profiling

5 employees
Biotechnology, Health Care
ADx NeuroSciences vs

Improving preclinical and clinical trial success rates with world-leading biomarkers & specialized l...

Private Equity
224 employees
Biotechnology, Health Care

FAQ About ADx NeuroSciences

ADx NeuroSciences develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. Both in vitro diagnostic...
ADx NeuroSciences was founded in 2011.
ADx NeuroSciences is headquartered in Belgium.
ADx NeuroSciences operates in the following industries: Biotechnology.
ADx NeuroSciences has approximately 23 employees.
Top alternatives and competitors to ADx NeuroSciences include ARCHIMEDlife Medical Laboratories, Metanomics Health, Nordic Bioscience, Pure MHC, LLC, Diadexus. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ADx NeuroSciences and ARCHIMEDlife Medical Laboratories are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ADx NeuroSciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy